Informations générales (source: ClinicalTrials.gov)
Elderly Cancer Patient: ELCAPA Cohort Survey (ELCAPA)
Observational
Assistance Publique - Hôpitaux de Paris (Voir sur ClinicalTrials)
septembre 2010
novembre 2027
29 juin 2024
The management of older patients with cancer has become a major public health concern in
Western countries because of the aging of the population and steady increase in cancer
incidence with advancing age. Cancer treatment of aged patients is complex due to
comorbidities, polypharmacy and functional status. The heterogeneity of the older
population in terms of comorbidities and functional status may explain the difficulty in
establishing management recommendations.
Study hypothesis is that a geriatric consultation using Geriatric Assessment (GA) can
evaluate patient's resource and strengths, in order to help oncologist to define the most
effective treatment. The GA developed by geriatricians and recommended by the
International Society of Geriatric Oncology (SIOG), is a multidimensional assessment of
general health status; comorbidities; functional status; nutritional, cognitive,
psychological, and social parameters; and medications. The GA uses validated geriatric
scales to produce an inventory of problems, which can then serve to develop an
individualized geriatric intervention plan; it may be an important step in selecting
elderly patients for cancer screening and treatment.
The objectives are:
- To assess the role of GA for decision making process for older patients with cancer
- To identify geriatric and oncologic factors associated with overall survival,
treatment feasibility, toxicities, morbidities
- To develop and/or validate screening tests for frailty in geriatric oncology
- To develop and validate frailty classifications
Method: The ELCAPA (ELderly CAncer PAtient) survey is a French multicentric prospective
study that includes all patients age 70 years or older who has a diagnosis of solid
cancer or hematologic malignancies in French hospitals
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT CURIE | 04/09/2024 13:49:55 | Contact (sur clinicalTrials) | |||
| CLCC RENE HUGUENIN INSTITUT CURIE | 04/09/2024 13:49:37 | Contact (sur clinicalTrials) | |||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| AP-HP - Hôpital Henri Mondor-Albert Chenevier | Contact (sur clinicalTrials) | ||||
Critères
Tous
Inclusion Criteria:
- Patient aged 70 years or older
- Diagnosed cancer at all stage
- Referred to a geriatrician for GA
- Given oral non-opposition from patient or a legally mandated person
- Patient aged 70 years or older
- Diagnosed cancer at all stage
- Referred to a geriatrician for GA
- Given oral non-opposition from patient or a legally mandated person
- Oral opposition